University of Maryland, Baltimore startup Harpoon Medical was acquired by Edwards Lifesciences for $100 million, Edwards announced Wednesday. The deal could rise to $150 million if Harpoon meets pre-specified milestones. Harpoon's primary product is a device designed to facilitate beating-heart, minimally invasive, echo-guided mitral valve repair. Clinical trials have shown that the product leads to positive safety